Sialorrhea: all 60 studies
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Application of Neuro-electrostimulation as a Treatment for Patients With Dry MouthRecruitingNCT07593495Not applicable
- Chewing Gum as a Therapeutic Intervention for the Management of HypersalivationNot yet recruitingNCT07158359Not applicable
- Effectiveness of Neuromuscular Electrical Stimulation Added to Oral Motor Therapy in Cerebral PalsyNot yet recruitingNCT07069257Not applicable
- Oral Structural and Functional Problems in Children With AutismNot yet recruitingNCT06355141
- Effects of Mollii Suit in Children With Non-Ambule Cerebral PalsyRecruitingNCT06259864Not applicable
- Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in AdultsCompletedNCT02610868Phase 3Results posted
- Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsCompletedNCT01994109Phase 3Results posted
- Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/ParkinsonismCompletedNCT01653132Phase 2Results posted
- A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's DiseaseCompletedNCT01370811Phase 2Results posted
- Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine SedationCompletedNCT01191398Not applicableResults posted
- Oral Health Literacy Tailored CommunicationCompletedNCT01118143Not applicableResults posted
- Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease PatientsCompletedNCT00761137Phase 2Results posted
- A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease PatientsCompletedNCT00515437Phase 2Results posted
- Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic ConditionsCompletedNCT00491894Phase 3Results posted
- A Retrospective Chart Abstraction to Investigate the Prevalence of Chronic Sialorrhea, and the Real-world Use of incobotulinumtoxinA Injections in Male and Female Participants Aged 18 Years and Older With Chronic SialorrheaCompletedNCT07881497
- Local Vibration for Drooling in Children With Cerebral PalsyCompletedNCT07626424Not applicable
- Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s DiseaseActive, not recruitingNCT07588191Not applicable
- Post-Covid-19 Patients Follow-up StudyCompletedNCT07571382Not applicable
- Effect of SCS Technique on Oromotor Skills in Children With CPActive, not recruitingNCT07516860Not applicable
- Cognitive-Integrated Soccer Training and PerformanceCompletedNCT07284940Not applicable
- A Clinical Study of Ultrasound-guided Botulinum Toxin A Into Salivary Gland for Sialorrhea After True Bulbar PalsyWithdrawnNCT07070817Not applicable
- Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic SialorrheaCompletedNCT07067762
- The Application of Lidocaine Cream on Oral Secretions of LMA Removal During the Recovery Period in Ophthalmic Surgical Patients Under General AnesthesiaWithdrawnNCT06967064Phase 4
- Oral Care of Intubated Intensive Care PatientCompletedNCT06258603Not applicable
- Botulinum Toxin Injection for Sialorrhea in Cerebral PalsyCompletedNCT06101160
- STN-DBS and the Risk of SialorrheaCompletedNCT06090929Not applicable
- Kinesio Taping Versus Oromotor Training on Drooling in Children With Spastic Cerebral PalsyCompletedNCT05524831Not applicable
- Pharmacokinetics of Atropine Oral GelCompletedNCT05164367Early Phase 1
- Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric SubjectsWithdrawnNCT05097079Phase 3
- Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,Status unknownNCT04873115Phase 4
- Excessive Crying in Children With Cerebral Palsy and Communication DeficitsCompletedNCT04523935Phase 4
- Effectiveness of Kinesiotaping and Manipulation Therapies in Drooling Management Among Children With Oral DysphagiaStatus unknownNCT04266626Not applicable
- Acute Salivary Flow Rate Response to Transcutaneous Electrical Nerve Stimulation Versus Electro-acupunctureStatus unknownNCT04211324
- Prevalence of Sialorrhea in Patients Treated With ClozapineCompletedNCT04197037
- Turkish Validation of The Drooling Impact ScaleStatus unknownNCT04132765
- Effects of Open and Closed System Suctioning on Suctioning Frequency and Amount of SecretionCompletedNCT04053751Not applicable
- Validation of the French Version of the Drooling Impact Scale in a Pediatric Cerebral Palsy PopulationCompletedNCT03986333
- Ipratropium Bromide Spray as Treatment for Sialorrhea in ChildrenStatus unknownNCT03747536Phase 2
- Safety and Efficacy of Cryoablation in Management of Sialorrhea in Patients With Neurological DisordersWithdrawnNCT03704168Not applicable
- Effect of Functional Chewing Training on Tongue Thrust and Drooling in Children With Cerebral PalsyCompletedNCT03194048Not applicable
- The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of TcellsStatus unknownNCT03057340Phase 1
- Management of Drooling in Children With Cerebral Palsy in FranceCompletedNCT02797106
- Clozapine-induced Hypersalivation - Feasibility TrialCompletedNCT02613494Phase 1/2
- Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological DiseasesCompletedNCT02425176Phase 2/3
- Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's DiseaseStatus unknownNCT02382198Phase 2
- Pilot Study of DRibble Vaccine for Prostate Cancer PatientsCompletedNCT02234921Phase 1
- Metoclopramide as Treatment of Clozapine-induced HypersalivationCompletedNCT02222220Phase 3
- Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia ServiceCompletedNCT02102542
- Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's PatientsCompletedNCT01844648Phase 2
- Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related SialorrheaCompletedNCT01551940Phase 2
- Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral PalsyStatus unknownNCT01489904Phase 2/3
- Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide SolutionCompletedNCT01429090Phase 1
- Implications of Pacifier Use in Israeli ChildrenStatus unknownNCT01249885
- The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in SchizophreniaStatus unknownNCT01045720Phase 2
- FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study SurveyCompletedNCT00683891
- Benzamide Derivates as Treatment of Clozapine-induced HypersalivationCompletedNCT00534573Phase 3
- Treatment of Clozapine-Induced Hypersalivation Ipratropium BromideCompletedNCT00381589Not applicable
- Ipratropium Spray for Drooling Saliva in Parkinson's DiseaseCompletedNCT00296946Phase 2
- Treatment of Drooling With Type A Botulinum Toxin in Children With Cerebral PalsyStatus unknownNCT00173745Not applicable
- Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00125203Phase 2/3